Hutchison China MediTech, also known as HUTCHMED, has disclosed an exclusive development and licensing agreement with a subsidiary of GlaxoSmithKline,...
-
-
Recent Updates
- ARC Group 2026 Capital M&A Forum Concludes Successfully in Shanghai: Exploring New Paths for Overseas Listing and Globalization Strategies of Chinese Enterprises
- Zhongkann Beidou Digital Group and Dahua Shares Strike Strategic Partnership
- HelioStar LightLink Raises Over 500 Million Yuan in Series A2 Funding to Build Space Laser Interconnect Base
- Tech Pilgrimage to China: A Glimpse into the Next Technological Revolution
- Moonshot Files Confidential Hong Kong IPO, Eyes $3 Billion Raise
- Asia-Pacific Countries Embrace Innovation for Economic Growth
- Hang Seng Closes Up 1.75% While Shanghai Slips into the Red
- China Extends Mortgage Terms to 40 Years and Tightens Presale Financing, Experts Concerned about Property Developers’ Funding Pressure
- US Lawmakers Call for Action on Uyghur Forced Labor Law Enforcement
- China’s Tech Industry Thrives Amid US Export Restrictions
Blogroll